Experts gather for trial design webinar

Just in case you hadn't heard already, we're doing an hour-long webinar at 2 p.m. EST this afternoon on the regulatory challenges involved in designing an oncology clinical trial. Few issues are more central to drug development and I feel sure that this would be time well spent for anyone interested in clinical trial design.

We've assembled a group of experts in a range of time zones for today's session.

Our panel includes Scott Cormack, President & Chief Executive Officer, OncoGenex Technologies; Taylor Burtis, Vice President of Regulatory, Quality and Compliance, Tokai Pharmaceuticals; and Christoph Zanke, Global Strategic Head Oncology, AAIPharma. These panelists have decades of experience designing and conducting clinical trials of new cancer drugs. The webinar is sponsored by AAIPharma.

Please join us later today. You can register here. -- John Carroll

Suggested Articles

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.

In our EuroBiotech roundup this week, Nordic Nanovector delays phase 2b readout, PPF buys big Autolus stake and Poxel shares phase 3 diabetes data.